Medical Research
(H40)
IRS Verified
DX Registered
990 on File
L-CMD RESEARCH FOUNDATION
Financial strength (30%)
61/100
Reliability (20%)
45/100
Effectiveness (25%)
90/100
Impact (25%)
50/100
CharityAI™ Score
Not yet evaluated
Mission Statement
Our Purpose: Inspired by our beautiful son Austin, this 501c3 nonprofit is dedicated to urgently translating scientific research into impactful treatments - and ultimately a cure - for L-CMD.
Financial Overview — FY 2025
$333K
Total Revenue
$407K
Total Expenses
$1.9M
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
97.7%
Fundraising Efficiency
N/A
Operating Reserve
57.16x
Liability-to-Asset
2.2%
Revenue Diversification
81.8%
Compared with Peers
FY 2025
Compared with 300 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
97.7% | 84.6% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
2.3% | 10.0% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
57.2 mo | 11.7 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
2.2% | 0.0% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
81.8% | 92.2% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-6.2% | 3.4% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
31.5% | 7.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-22.3% | -1.6% |
P10P90
|
Impact
1 program| Outcome / Program | People Served | Cost / Service | # Completed | Duration |
|---|---|---|---|---|
| Creation of treatments/a cure for L-CMD | 200 | $10,000.00 | — | Lifetime |
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $333K | $407K | $1.9M | 97.7% | 0 |
| 2024 | $355K | $309K | $2.0M | 98.7% | 0 |
| 2023 | $313K | $82K | $2.0M | 93.6% | 0 |
| 2022 | $351K | $77K | $1.7M | 86.8% | 0 |
| 2021 | $2.9M | $45K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.